On Aug. 11, 2020, Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273. The award of up to $1.525 billion is for the manufacturing and delivery of 100 million doses of mRNA-1273. With the previous award of up to $955 million from BARDA for the development of mRNA-1273 to licensure, tthe announcement brings the U.S. government commitments for early access to mRNA-1273 to up to $2.48 billion.

Under the terms of the agreement, the U.S. government, as a part of Operation Warp Speed, will also have the option to purchase up to an additional 400 million doses of mRNA-1273 from Moderna.